HOME  >  Online journal

Vol.51 No.2 contents

Japanese/English

Full Text of PDF (497K) Article in Japanese

- The 24th Lung Cancer Workshop -

Outpatient Chemotherapy for Non-small-cell Lung Cancer

Tomonori Hirashima¹, Yohko Kondoh², Yoshie Tokuoka³, Naoko Morishita⁴, Yuka Matsuura¹, Motohiro Tamiya¹, Hidekazu Suzuki¹, Shinji Sasada¹, Norio Okamoto¹, Masashi Kobayashi^4
1Department of Thoracic Malignancy, ²Pharmacy, ³Nursing Department, ⁴Department of Outpatient Treatment, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Japan

---

Objective. We evaluated the current status of outpatient chemotherapy at our institute. We examined the regimens of outpatient chemotherapy, cycles of each regimen, and long-term survivors in patients with advanced non-small-cell lung cancer (NSCLC). Methods. We retrospectively evaluated patients who received at least 1 regimen of outpatient chemotherapy at our institution between September 2004 and May 2009. Results. A total of 450 patients received outpatient chemotherapy, without serious adverse reactions. Of these, 306 had NSCLC, 71 had small-cell lung cancer, 63 had other tumors, and 10 had rheumatoid arthritis. Of the NSCLC patients, 187 had stage IIIB NSCLC with no radical thoracic radiotherapy or stage IV NSCLC, and 22 of these 187 patients survived 3 for years or more. Many of the long-term survivors received a considerable number of chemotherapy regimens and cycles. Conclusion. Outpatient chemotherapy at our institution extended the duration of chemotherapy, which may improve the survival of NSCLC patients.
key words: Outpatient chemotherapy, Non-small-cell lung cancer, Long-term survivors

JJLC 51 (2): 113-118, 2011